Evidence map›Paper›PMID 35662411›Full record

ArticleCell reports2022

Single-cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection.

Suhas Sureshchandra, Michael Z Zulu, Brianna M Doratt, Allen Jankeel, Delia Tifrea, Robert Edwards, Monica Rincon, Nicole E Marshall, Ilhem Messaoudi

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. CD4Frontiers in immunology · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Suhas SureshchandraDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, CA 92697, USA.
Michael Z ZuluDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, CA 92697, USA.
Brianna M DorattDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, CA 92697, USA; Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.
Allen JankeelDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA.
Delia TifreaDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, CA 92697, USA.
Robert EdwardsDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, CA 92697, USA.
Monica RinconMaternal-Fetal Medicine, Oregon Health and Sciences University, Portland, OR 97239, USA.
Nicole E MarshallMaternal-Fetal Medicine, Oregon Health and Sciences University, Portland, OR 97239, USA.
Ilhem MessaoudiDepartment of Molecular Biology and Biochemistry, School of Biological Sciences, University of California, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, CA 92697, USA; Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA. Electronic address: Ilhem.messaoudi@uky.edu.
University of California, Irvine · USOregon Health & Science University · USUniversity of Kentucky · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Dysregulation of maternal immunity during pregnancy by pregravid obesityR01AI145910 · NIAID · UNIVERSITY OF KENTUCKY · PI MESSAOUDI, ILHEM · 2019 to 2024
$3.4M
Maternal obesity and neonatal innate immunityR01AI142841 · NIAID · UNIVERSITY OF KENTUCKY · PI MESSAOUDI, ILHEM, VARLAMOV, OLEG · 2018 to 2024
$2.7M
Maternal Body Composition Regulates Placental Function and Fetal GrowthK23HD069520 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI MARSHALL, NICOLE ELISE · 2014 to 2017
$540k
NCATS NIH HHS UL1 TR001414NCI NIH HHS P30 CA062203NIAID NIH HHS R01 AI142841NIAID NIH HHS R01 AI145910NICHD NIH HHS K23 HD069520
6 · The paper itself

Abstract

While severe coronavirus 2019 (COVID-19) is associated with immune activation at the maternal-fetal interface, responses to asymptomatic/mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy remain unknown. Here, we assess immunological adaptations in blood and term decidua in response to asymptomatic/mild disease in pregnant women. We report attenuated antigen presentation and type I interferon (IFN) signaling pathways, loss of tissue-resident decidual macrophages, and upregulated cytokine/chemokine signaling in monocyte-derived decidual macrophages. Furthermore, we describe increased frequencies of activated tissue-resident T cells and decreased abundance of regulatory T cells with infection while frequencies of cytotoxic CD4/CD8 T cells are increased in the blood. In contrast to decidual macrophages, type I IFN signaling is higher in decidual T cells. Finally, infection leads to a narrowing of T cell receptor diversity in both blood and decidua. Collectively, these observations indicate that asymptomatic/mild COVID-19 during pregnancy results in remodeling of the immunological landscape of the maternal-fetal interface, with a potential for long-term adverse outcomes for the offspring.

Indexed as

COVID-19DeciduaFemaleHumansPlacentaPregnancySARS-CoV-2Sequence Analysis, RNACOVID-19CP: ImmunologyCP: MicrobiologydeciduamacrophagesplacentapregnancySARS-CoV-2T cellsTCR

Identifiers

PMID35662411
PMCPMC9130636
OpenAlexW4281476559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.